IL6 and rheumatoid arthritis: Previous studies have shown that overexpression of lncRNA DILC may improve RA by downregulating interleukin 6 (IL-6) and inhibiting the apoptosis of human fibroblast-like synovial cells (HFLS) (Wang et al., 2019).